Correction of a Factor VIII genomic inversion with designer recombinases
PromethION-based whole genome sequencing of endothelial cells differentiated from patient derived induced pluripotent stem cells (iPSCs) of a hemophilic donor, transiently treated with a Cre recombinase, a RecF8 recombinase, and untreated cells. The dataset contains fastq files with all sequencing reads passing the standard quality filtering.
- 3 samples
- DAC: EGAC00001002238
- Technology: PromethION
Harmonised Data Access Agreement (hDAA) for Controlled Access Data
Harmonised Data Access Agreement (hDAA) for Controlled Access Data
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001005496 | Other |